The global anti-malarial drugs market was valued at around US$ 948.5 Million at the end of 2021. The market is projected to register a 4.8% CAGR and top a valuation of US$ 1515.8 Million by 2032.
Due to increased research for novel medications and new combination therapies the anti-malarial drugs market is set to experience significant revenue growth in the coming times.
Malaria is a contagious illness that spreads when a female Anopheles mosquito bites a host, allowing parasites to enter the body. Fever, exhaustion, nausea, and headaches are additional symptoms brought on by the destruction of red blood cells by merozoites, which also proliferate inside them. Antimalarial drugs are those that are used to treat and ward against malaria infections. Several drugs are available in the market for the treatment of malarial infection such as quinine, chloroquine, proguanil, mefloquine, and pyrimethamine.
| Attributes | Details |
| Anti-Malarial Drugs Market Value in 2021 | USD 948.5 Million |
| Anti-Malarial Drugs Market Value in 2032 | USD 1515.8 Million |
| Anti-Malarial Drugs Market CAGR (2022 to 2032) | 4.8% |
The high prevalence of malaria in affected nations increased public awareness due to government initiatives to reduce the prevalence rate of malaria by conducting various campaigns for spreading awareness about the prevention of malaria, and increased research for the development of novel drugs and new combination therapies, among other things, are the factors that are driving the growth of anti-malarial drugs market.
One of the aspects driving the market's development is the rise in the incidence of traveler’s malaria. Numerous tourists from around the world visit malaria-infected nations each year, which is predicted to raise the risk of disease.
Strong efforts made by various regional and international governments and regulating agencies, including the USA Food and Drug Administration (FDA), to reduce the prevalence of the malarial disease worldwide are also seen to be a major driver of the market for anti-malarial drugs. Other key elements fueling the expansion of the global market for anti-malarial drugs are the presence of significant players, improved Research and Development facilities, and healthcare expenditure.
The anti-malarial drugs market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Africa is the leading region in the global anti-malarial drugs market owing to the high prevalence of malarial infection in various nations in the region and various healthcare facilities provided by global health agencies.
Increasing regulatory approval of the medications and the presence of major pharmaceutical companies are predicted to contribute to the lucrative development of the anti-malarial drug market in East Asia in the coming years.
The South American region is also predicted to show lucrative growth due to increasing awareness regarding the use of anti-malaria drugs for the early diagnosis of malarial disease.
Alvizia Healthcare Pvt. Ltd., Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Zydus Cadila, Lincoln Pharmaceuticals, Strides Pharma Science, Glenmark Pharmaceuticals, Alliance Pharmaceuticals.
| Report Attributes | Details |
| Growth Rate | CAGR of 4.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Million, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segment Covered |
|
| Region Covered |
|
| Key Countries Profiled |
|
| Key Players |
|
| Customization | Available Upon Request |
The global anti-malarial drugs market is anticipated to register a CAGR of 4.8% during the forecast period.
The global anti-malarial drugs market is projected to be about US$ 1515.8 Million by the end of the year 2032.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Drugs Glass Packaging Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Orphan Drugs Market Size and Share Forecast Outlook 2025 to 2035
Topical Drugs Packaging Market Growth & Forecast 2025 to 2035
Retinal Drugs And Biologics Market
Antiviral Drugs Market Size and Share Forecast Outlook 2025 to 2035
Cytotoxic Drugs Market Analysis – Growth, Trends & Forecast 2025-2035
3D Printed Drugs Market Outlook – Growth, Demand & Forecast 2025-2035
Depression Drugs Market
Parenteral Drugs Packaging Market
Brain Tumor Drugs Market Forecast & Analysis: 2025 to 2035
Infertility Drugs Market Analysis - Size, Share & Forecast 2025 to 2035
Expectorant Drugs Market Trend Analysis Based on Drug, Dosage Form, Product, Distribution Channel, and Region 2025 to 2035
Cannabinoid Drugs Market
Clot Busting Drugs Market Size and Share Forecast Outlook 2025 to 2035
Psychotropic Drugs Market Growth - Industry Trends & Outlook 2025 to 2035
Critical Care Drugs Market Analysis – Trends, Demand & Forecast 2024-2034
Antimetabolite Drugs Market Size and Share Forecast Outlook 2025 to 2035
Fish-Oil Based Drugs Market Analysis – Trends, Share & Growth Forecast 2024-2034
Plasma-Derived Drugs Market
Antithrombotic Drugs Market
Anti-Malarial drugs Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
